Internal medicine, Randomized controlled trial, Surgery, Meta-analysis and Confidence interval are his primary areas of study. His Internal medicine study integrates concerns from other disciplines, such as Placebo, Acquired immunodeficiency syndrome and Immunology. Heiner C. Bucher interconnects Odds ratio, Observational study, Discontinuation, Chemoprophylaxis and Cause of death in the investigation of issues within Randomized controlled trial.
The Surgery study combines topics in areas such as Stroke, Relative risk, Emergency medicine and Diet therapy. His Meta-analysis research focuses on Body mass index and how it connects with Weight loss. The concepts of his Confidence interval study are interwoven with issues in Coronary artery disease, Cardiology and Endocrinology, Blood pressure.
Heiner C. Bucher mainly focuses on Internal medicine, Cohort study, Randomized controlled trial, Surgery and Confidence interval. His Internal medicine research includes themes of Viral load, Acquired immunodeficiency syndrome and Immunology. Heiner C. Bucher has included themes like Epidemiology, Incidence, Regimen, Prospective cohort study and Cohort in his Cohort study study.
His Randomized controlled trial study combines topics in areas such as Clinical trial, Antibiotics, Relative risk, Intensive care medicine and Pediatrics. His Surgery research incorporates themes from Placebo and Adverse effect. His work carried out in the field of Confidence interval brings together such families of science as Interquartile range, Blood pressure and Emergency medicine.
The scientist’s investigation covers issues in Internal medicine, Randomized controlled trial, Cohort study, Interquartile range and Odds ratio. His study in Meta-analysis, Cohort, Cancer, Adverse effect and Regimen falls under the purview of Internal medicine. In the field of Meta-analysis, his study on Publication bias overlaps with subjects such as Acetylcholinesterase.
Heiner C. Bucher interconnects Clinical trial, Pediatrics and Hazard ratio in the investigation of issues within Randomized controlled trial. His Cohort study study combines topics from a wide range of disciplines, such as Aneurysm, Ambulatory care, Health policy, Record linkage and Subarachnoid hemorrhage. His research investigates the connection between Odds ratio and topics such as Confidence interval that intersect with issues in Case-control study, Transmission and Obstetrics.
His main research concerns Randomized controlled trial, Internal medicine, Clinical trial, Interquartile range and Meta-analysis. His studies deal with areas such as Sensitivity analyses, Pediatrics and Intensive care medicine as well as Randomized controlled trial. His work on Cohort study, Cohort and Incidence as part of general Internal medicine study is frequently linked to Institutional repository, therefore connecting diverse disciplines of science.
His Clinical trial research integrates issues from Off-label use, Marketing authorization, Cochrane Library and Study heterogeneity. The Interquartile range study combines topics in areas such as Descriptive research, Emergency medicine, Clinical study design, Confidence interval and Confounding. His study looks at the intersection of Meta-analysis and topics like Odds ratio with Comorbidity.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
The Results of Direct and Indirect Treatment Comparisons in Meta-Analysis of Randomized Controlled Trials
Heiner C. Bucher;Gordon H. Guyatt;Lauren E. Griffith;Stephen D. Walter.
Journal of Clinical Epidemiology (1997)
Effects of Low-Carbohydrate vs Low-Fat Diets on Weight Loss and Cardiovascular Risk Factors A Meta-analysis of Randomized Controlled Trials
Alain J. Nordmann;Abigail Nordmann;Matthias Briel;Ulrich Keller.
JAMA Internal Medicine (2006)
N-3 polyunsaturated fatty acids in coronary heart disease: a meta-analysis of randomized controlled trials.
Heiner C Bucher;Peter Hengstler;Christian Schindler;Gabriela Meier.
The American Journal of Medicine (2002)
Effect of Procalcitonin-Based Guidelines vs Standard Guidelines on Antibiotic Use in Lower Respiratory Tract Infections: The ProHOSP Randomized Controlled Trial
Philipp Schuetz;Mirjam Christ-Crain;Robert Thomann;Claudine Falconnier.
Bariatric surgery versus non-surgical treatment for obesity: a systematic review and meta-analysis of randomised controlled trials
Viktoria L Gloy;Matthias Briel;Matthias Briel;Deepak L Bhatt;Sangeeta R Kashyap.
Randomized trials stopped early for benefit: a systematic review
Victor M. Montori;P. J. Devereaux;Neill K. J. Adhikari;Neill K. J. Adhikari;Karen E. A. Burns;Karen E. A. Burns.
Mortality in randomized controlled trials comparing drug-eluting vs. bare metal stents in coronary artery disease: a meta-analysis
Alain Joel Nordmann;Matthias Briel;Heiner Claudins Bucher.
European Heart Journal (2006)
Procalcitonin to initiate or discontinue antibiotics in acute respiratory tract infections
Philipp Schuetz;Yannick Wirz;Ramon Sager;Mirjam Christ-Crain.
Cochrane Database of Systematic Reviews (2017)
Association between change in high density lipoprotein cholesterol and cardiovascular disease morbidity and mortality: systematic review and meta-regression analysis
Matthias Briel;Matthias Briel;Ignacio Ferreira-Gonzalez;John J You;Paul J Karanicolas.
Procalcitonin-guided antibiotic use vs a standard approach for acute respiratory tract infections in primary care.
Matthias Briel;Philipp Schuetz;Beat Mueller;Jim Young.
JAMA Internal Medicine (2008)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: